| Recommended Mapping (based on statistical analysis) |
| Source ICD-9 | Mapping Type | Target ICD-10 |
| 99529 (Diagnosis) - Adv eff med/biol NEC/NOS (Unspecified adverse effect of other drug, medicinal and biological substance) with E9411 (Diagnosis) - Adv eff parasympatholytc (Parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics causing adverse effects in therapeutic use) | Cluster To Single | T443X5A (Diagnosis) - Adverse effect of parasympatholytics and spasmolytics, init (Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter) |
| CMS/CDC General Equivalence Mappings |
| 99529 (Diagnosis) - Adv eff med/biol NEC/NOS (Unspecified adverse effect of other drug, medicinal and biological substance) with E9411 (Diagnosis) - Adv eff parasympatholytc (Parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics causing adverse effects in therapeutic use) | Cluster To Single | Alternative #1: T443X5A (Diagnosis) - Adverse effect of parasympatholytics and spasmolytics, init (Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter) |
| Recommended Mapping (based on statistical analysis) |
| Source ICD-9 | Mapping Type | Target ICD-10 |
| 9095 (Diagnosis) - Lte efct advrs efct drug (Late effect of adverse effect of drug, medicinal or biological substance) with E9411 (Diagnosis) - Adv eff parasympatholytc (Parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics causing adverse effects in therapeutic use) | Cluster To Single | T443X5S (Diagnosis) - Adverse effect of parasympath and spasmolytics, sequela (Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela) |
| CMS/CDC General Equivalence Mappings |
| 9095 (Diagnosis) - Lte efct advrs efct drug (Late effect of adverse effect of drug, medicinal or biological substance) with E9411 (Diagnosis) - Adv eff parasympatholytc (Parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics causing adverse effects in therapeutic use) | Cluster To Single | Alternative #1: T443X5S (Diagnosis) - Adverse effect of parasympath and spasmolytics, sequela (Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela) |